(8aR)-7-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;2,7-diazaspiro[4.4]nonan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;2,8-diazaspiro[5.5]undecan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;6,8-dihydro-5H-1,7-naphthyridin-7-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;5-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-3,4,6,7-tetrahydro-2H-pyrrolo[3,4-c]pyridin-1-one

C137H157N25O8S10 — CID 164990759

IUPAC(8aR)-7-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;2,7-diazaspiro[4.4]nonan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;2,8-diazaspiro[5.5]undecan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;6,8-dihydro-5H-1,7-naphthyridin-7-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;5-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-3,4,6,7-tetrahydro-2H-pyrrolo[3,4-c]pyridin-1-one
SMILESCSc1cnc(C[C@H]2CC[C@H](Cc3nc4ccc(C(=O)N5CCC6(CCNC6)C5)cc4s3)C2)nc1.CSc1cnc(C[C@H]2CC[C@H](Cc3nc4ccc(C(=O)N5CCC6=C(CNC6=O)C5)cc4s3)C2)nc1.CSc1cnc(C[C@H]2CC[C@H](Cc3nc4ccc(C(=O)N5CCCC6(CCCNC6)C5)cc4s3)C2)nc1.CSc1cnc(C[C@H]2CC[C@H](Cc3nc4ccc(C(=O)N5CCN6C(=O)OC[C@H]6C5)cc4s3)C2)nc1.CSc1cnc(C[C@H]2CC[C@H](Cc3nc4ccc(C(=O)N5CCc6cccnc6C5)cc4s3)C2)nc1
InChIInChI=1S/C29H37N5OS2.C28H29N5OS2.C27H29N5O2S2.C27H33N5OS2.C26H29N5O3S2/c1-36-23-16-31-26(32-17-23)13-20-4-5-21(12-20)14-27-33-24-7-6-22(15-25(24)37-27)28(35)34-11-3-9-29(19-34)8-2-10-30-18-29;1-35-22-15-30-26(31-16-22)12-18-4-5-19(11-18)13-27-32-23-7-6-21(14-25(23)36-27)28(34)33-10-8-20-3-2-9-29-24(20)17-33;1-35-20-13-28-24(29-14-20)9-16-2-3-17(8-16)10-25-31-22-5-4-18(11-23(22)36-25)27(34)32-7-6-21-19(15-32)12-30-26(21)33;1-34-21-14-29-24(30-15-21)11-18-2-3-19(10-18)12-25-31-22-5-4-20(13-23(22)35-25)26(33)32-9-7-27(17-32)6-8-28-16-27;1-35-20-12-27-23(28-13-20)9-16-2-3-17(8-16)10-24-29-21-5-4-18(11-22(21)36-24)25(32)30-6-7-31-19(14-30)15-34-26(31)33/h6-7,15-17,20-21,30H,2-5,8-14,18-19H2,1H3;2-3,6-7,9,14-16,18-19H,4-5,8,10-13,17H2,1H3;4-5,11,13-14,16-17H,2-3,6-10,12,15H2,1H3,(H,30,33);4-5,13-15,18-19,28H,2-3,6-12,16-17H2,1H3;4-5,11-13,16-17,19H,2-3,6-10,14-15H2,1H3/t20-,21-,29?;18-,19-;16-,17-;18-,19-,27?;16-,17-,19+/m00000/s1
InChIKeyGUYYTQALZYNXRS-ZNCZOHJPSA-N
MW2602.60 g/mol
LogP24.62
Rot. Bonds30

About (8aR)-7-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;2,7-diazaspiro[4.4]nonan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;2,8-diazaspiro[5.5]undecan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;6,8-dihydro-5H-1,7-naphthyridin-7-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;5-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-3,4,6,7-tetrahydro-2H-pyrrolo[3,4-c]pyridin-1-one

(8aR)-7-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;2,7-diazaspiro[4.4]nonan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;2,8-diazaspiro[5.5]undecan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;6,8-dihydro-5H-1,7-naphthyridin-7-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;5-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-3,4,6,7-tetrahydro-2H-pyrrolo[3,4-c]pyridin-1-one (PubChem CID 164990759) has the molecular formula C137H157N25O8S10 and a molecular weight of 2602.60 g/mol. Its IUPAC name is (8aR)-7-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;2,7-diazaspiro[4.4]nonan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;2,8-diazaspiro[5.5]undecan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;6,8-dihydro-5H-1,7-naphthyridin-7-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;5-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-3,4,6,7-tetrahydro-2H-pyrrolo[3,4-c]pyridin-1-one.

Molecular Properties

Compound Name(8aR)-7-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;2,7-diazaspiro[4.4]nonan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;2,8-diazaspiro[5.5]undecan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;6,8-dihydro-5H-1,7-naphthyridin-7-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;5-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-3,4,6,7-tetrahydro-2H-pyrrolo[3,4-c]pyridin-1-one
PubChem CID164990759
Molecular FormulaC137H157N25O8S10
Molecular Weight2602.60 g/mol
Exact Mass2599.99
IUPAC Name(8aR)-7-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;2,7-diazaspiro[4.4]nonan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;2,8-diazaspiro[5.5]undecan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;6,8-dihydro-5H-1,7-naphthyridin-7-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;5-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-3,4,6,7-tetrahydro-2H-pyrrolo[3,4-c]pyridin-1-one
SMILESCSc1cnc(C[C@H]2CC[C@H](Cc3nc4ccc(C(=O)N5CCC6(CCNC6)C5)cc4s3)C2)nc1.CSc1cnc(C[C@H]2CC[C@H](Cc3nc4ccc(C(=O)N5CCC6=C(CNC6=O)C5)cc4s3)C2)nc1.CSc1cnc(C[C@H]2CC[C@H](Cc3nc4ccc(C(=O)N5CCCC6(CCCNC6)C5)cc4s3)C2)nc1.CSc1cnc(C[C@H]2CC[C@H](Cc3nc4ccc(C(=O)N5CCN6C(=O)OC[C@H]6C5)cc4s3)C2)nc1.CSc1cnc(C[C@H]2CC[C@H](Cc3nc4ccc(C(=O)N5CCc6cccnc6C5)cc4s3)C2)nc1
InChIInChI=1S/C29H37N5OS2.C28H29N5OS2.C27H29N5O2S2.C27H33N5OS2.C26H29N5O3S2/c1-36-23-16-31-26(32-17-23)13-20-4-5-21(12-20)14-27-33-24-7-6-22(15-25(24)37-27)28(35)34-11-3-9-29(19-34)8-2-10-30-18-29;1-35-22-15-30-26(31-16-22)12-18-4-5-19(11-18)13-27-32-23-7-6-21(14-25(23)36-27)28(34)33-10-8-20-3-2-9-29-24(20)17-33;1-35-20-13-28-24(29-14-20)9-16-2-3-17(8-16)10-25-31-22-5-4-18(11-23(22)36-25)27(34)32-7-6-21-19(15-32)12-30-26(21)33;1-34-21-14-29-24(30-15-21)11-18-2-3-19(10-18)12-25-31-22-5-4-20(13-23(22)35-25)26(33)32-9-7-27(17-32)6-8-28-16-27;1-35-20-12-27-23(28-13-20)9-16-2-3-17(8-16)10-24-29-21-5-4-18(11-22(21)36-24)25(32)30-6-7-31-19(14-30)15-34-26(31)33/h6-7,15-17,20-21,30H,2-5,8-14,18-19H2,1H3;2-3,6-7,9,14-16,18-19H,4-5,8,10-13,17H2,1H3;4-5,11,13-14,16-17H,2-3,6-10,12,15H2,1H3,(H,30,33);4-5,13-15,18-19,28H,2-3,6-12,16-17H2,1H3;4-5,11-13,16-17,19H,2-3,6-10,14-15H2,1H3/t20-,21-,29?;18-,19-;16-,17-;18-,19-,27?;16-,17-,19+/m00000/s1
InChIKeyGUYYTQALZYNXRS-ZNCZOHJPSA-N
XLogP24.62
TPSA390.49 Ų
H-Bond Donors3
H-Bond Acceptors36
Rotatable Bonds30
Heavy Atoms180
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002602.60
LogP ≤ 524.62
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1036

Analyze (8aR)-7-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;2,7-diazaspiro[4.4]nonan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;2,8-diazaspiro[5.5]undecan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;6,8-dihydro-5H-1,7-naphthyridin-7-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;5-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-3,4,6,7-tetrahydro-2H-pyrrolo[3,4-c]pyridin-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (8aR)-7-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;2,7-diazaspiro[4.4]nonan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;2,8-diazaspiro[5.5]undecan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;6,8-dihydro-5H-1,7-naphthyridin-7-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;5-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-3,4,6,7-tetrahydro-2H-pyrrolo[3,4-c]pyridin-1-one?
The IUPAC name of (8aR)-7-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;2,7-diazaspiro[4.4]nonan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;2,8-diazaspiro[5.5]undecan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;6,8-dihydro-5H-1,7-naphthyridin-7-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;5-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-3,4,6,7-tetrahydro-2H-pyrrolo[3,4-c]pyridin-1-one (CID 164990759) is (8aR)-7-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;2,7-diazaspiro[4.4]nonan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;2,8-diazaspiro[5.5]undecan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;6,8-dihydro-5H-1,7-naphthyridin-7-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;5-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-3,4,6,7-tetrahydro-2H-pyrrolo[3,4-c]pyridin-1-one.
What is the SMILES notation for (8aR)-7-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;2,7-diazaspiro[4.4]nonan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;2,8-diazaspiro[5.5]undecan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;6,8-dihydro-5H-1,7-naphthyridin-7-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;5-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-3,4,6,7-tetrahydro-2H-pyrrolo[3,4-c]pyridin-1-one?
The canonical SMILES for (8aR)-7-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;2,7-diazaspiro[4.4]nonan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;2,8-diazaspiro[5.5]undecan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;6,8-dihydro-5H-1,7-naphthyridin-7-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;5-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-3,4,6,7-tetrahydro-2H-pyrrolo[3,4-c]pyridin-1-one is CSc1cnc(C[C@H]2CC[C@H](Cc3nc4ccc(C(=O)N5CCC6(CCNC6)C5)cc4s3)C2)nc1.CSc1cnc(C[C@H]2CC[C@H](Cc3nc4ccc(C(=O)N5CCC6=C(CNC6=O)C5)cc4s3)C2)nc1.CSc1cnc(C[C@H]2CC[C@H](Cc3nc4ccc(C(=O)N5CCCC6(CCCNC6)C5)cc4s3)C2)nc1.CSc1cnc(C[C@H]2CC[C@H](Cc3nc4ccc(C(=O)N5CCN6C(=O)OC[C@H]6C5)cc4s3)C2)nc1.CSc1cnc(C[C@H]2CC[C@H](Cc3nc4ccc(C(=O)N5CCc6cccnc6C5)cc4s3)C2)nc1.
What is the InChIKey of (8aR)-7-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;2,7-diazaspiro[4.4]nonan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;2,8-diazaspiro[5.5]undecan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;6,8-dihydro-5H-1,7-naphthyridin-7-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;5-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-3,4,6,7-tetrahydro-2H-pyrrolo[3,4-c]pyridin-1-one?
The InChIKey is GUYYTQALZYNXRS-ZNCZOHJPSA-N. The full InChI is InChI=1S/C29H37N5OS2.C28H29N5OS2.C27H29N5O2S2.C27H33N5OS2.C26H29N5O3S2/c1-36-23-16-31-26(32-17-23)13-20-4-5-21(12-20)14-27-33-24-7-6-22(15-25(24)37-27)28(35)34-11-3-9-29(19-34)8-2-10-30-18-29;1-35-22-15-30-26(31-16-22)12-18-4-5-19(11-18)13-27-32-23-7-6-21(14-25(23)36-27)28(34)33-10-8-20-3-2-9-29-24(20)17-33;1-35-20-13-28-24(29-14-20)9-16-2-3-17(8-16)10-25-31-22-5-4-18(11-23(22)36-25)27(34)32-7-6-21-19(15-32)12-30-26(21)33;1-34-21-14-29-24(30-15-21)11-18-2-3-19(10-18)12-25-31-22-5-4-20(13-23(22)35-25)26(33)32-9-7-27(17-32)6-8-28-16-27;1-35-20-12-27-23(28-13-20)9-16-2-3-17(8-16)10-24-29-21-5-4-18(11-22(21)36-24)25(32)30-6-7-31-19(14-30)15-34-26(31)33/h6-7,15-17,20-21,30H,2-5,8-14,18-19H2,1H3;2-3,6-7,9,14-16,18-19H,4-5,8,10-13,17H2,1H3;4-5,11,13-14,16-17H,2-3,6-10,12,15H2,1H3,(H,30,33);4-5,13-15,18-19,28H,2-3,6-12,16-17H2,1H3;4-5,11-13,16-17,19H,2-3,6-10,14-15H2,1H3/t20-,21-,29?;18-,19-;16-,17-;18-,19-,27?;16-,17-,19+/m00000/s1.
What are the key properties of (8aR)-7-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;2,7-diazaspiro[4.4]nonan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;2,8-diazaspiro[5.5]undecan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;6,8-dihydro-5H-1,7-naphthyridin-7-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;5-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-3,4,6,7-tetrahydro-2H-pyrrolo[3,4-c]pyridin-1-one?
(8aR)-7-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;2,7-diazaspiro[4.4]nonan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;2,8-diazaspiro[5.5]undecan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;6,8-dihydro-5H-1,7-naphthyridin-7-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;5-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-3,4,6,7-tetrahydro-2H-pyrrolo[3,4-c]pyridin-1-one has a molecular weight of 2602.60 g/mol, XLogP of 24.62, 30 rotatable bonds, 3 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for (8aR)-7-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;2,7-diazaspiro[4.4]nonan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;2,8-diazaspiro[5.5]undecan-2-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;6,8-dihydro-5H-1,7-naphthyridin-7-yl-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazol-6-yl]methanone;5-[2-[[(1S,3S)-3-[(5-methylsulfanylpyrimidin-2-yl)methyl]cyclopentyl]methyl]-1,3-benzothiazole-6-carbonyl]-3,4,6,7-tetrahydro-2H-pyrrolo[3,4-c]pyridin-1-one is sourced from PubChem (CID 164990759), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).